Medical Devices
The GAO has recently issued a report on medical devices. The thrust of the report is that “high-risk” medical devices do not receive enough scrutiny . . .
Medical Devices
Beer v. Pot, Public Choice Edition
The political economy of alcohol regulation has always been fascinating. But things took an interesting turn of late (HT: Marginal Revolution) when a beer industry . . .
The FTC Loses in Ovation Pharmaceuticals
There are some new developments in the Federal Trade Commission’s consummated merger case brought against Ovation. Namely, the FTC has lost. TOTM readers may recall . . .
Delaware’s Future
I share Prof. Ribstein’s concerns about the federalization of corporate governance contained in the Dodd bill. Though Senator Carper wasn’t able, in the end, to . . .
Comments on Jonathan Baker’s Preserving a Political Bargain
I’ve recently finished reading Jonathan Baker’s Preserving a Political Bargain: The Political Economy of the Non-Interventionist Challenge to Monopolization Enforcement, forthcoming in the Antitrust Law . . .
The Girl Scouts and Section 5
It turns out that the Girl Scouts price discriminate, i.e. they charge different prices for the same product in different parts of the country (HT: . . .
Is the Intel/AMD Settlement Illegal?
So, AMD and Intel settled. Its a case we’ve covered here in significant detail. Terms haven’t been announced publicly. AAI has predictably argued that the . . .
Reverse Payments Settlements and Upcoming Congressional Action
In light of the recent political focus on healthcare, several Congressional bills propose to single out a class of contracts between pharmaceutical companies for closer . . .
Ovation Reconsidered: A Response to Commissioner Leary
I was very pleased to thumb through the newest version of Antitrust Magazine and see a TOTM post get some attention. Its always nice to . . .